Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jamie J. Kisgen"'
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials, Vol 17, Iss 1, Pp 1-6 (2018)
Abstract Background Clostridium difficile-associated diarrhea (CDAD) is a major public health threat that results in increased length of stay, hospital readmissions, deaths, and economic burden. CDAD treatment is often guided by severity of disease.
Externí odkaz:
https://doaj.org/article/a4a3e607f56642d9ad704a8a2b73632e
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials, Vol 17, Iss 1, Pp 1-6 (2018)
Annals of Clinical Microbiology and Antimicrobials
Annals of Clinical Microbiology and Antimicrobials
Background Clostridium difficile-associated diarrhea (CDAD) is a major public health threat that results in increased length of stay, hospital readmissions, deaths, and economic burden. CDAD treatment is often guided by severity of disease. Although
Autor:
Jamie J Kisgen, Spencer H Durham, P. Brandon Bookstaver, Christopher M. Bland, Timothy P. Gauthier, Elias B. Chahine, Marylee V. Worley, Daniel B Chastain, Bruce M Jones, Krutika N Mediwala, Brandon Hill, Kayla R. Stover, Ashley Marx
Publikováno v:
Open Forum Infectious Diseases
With an increasing number of antimicrobial stewardship–related articles published each year, attempting to stay current is challenging. The Southeastern Research Group Endeavor (SERGE-45) identified antimicrobial stewardship–related peer-reviewed
Publikováno v:
Open Forum Infectious Diseases
Background Optimal treatment of meningitis relies on prompt diagnostic evaluation and initiation of appropriate antimicrobials. The meningitis/encephalitis panel (MEP) is a multiplex rapid polymerase chain reaction, with the ability to detect 14 comm
Publikováno v:
Open Forum Infectious Diseases
Background Current IDSA guidelines recommend targeting a vancomycin trough between 15 and 20 mg/L to achieve an AUC/MIC ≥ 400; however, recent literature shows increased rates of nephrotoxicity within this range and the target AUC/MIC ratio may be
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 71(8)
Purpose The mechanism of action, pharmacokinetics, pharmacodynamics, and clinical efficacy and safety of an investigational second-generation oxazolidinone are reviewed. Summary Tedizolid is a protein synthesis inhibitor in clinical development for t
Autor:
Cole KA; Medical Science Liaison, OH/MI/W. PA, ViiV Healthcare, Research Triangle Park, North Carolina, USA., Zhou AY; Department of Pharmacy, Loma Linda University Health, Loma Linda, California, USA., Jones T; Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA., Moore WJ; Department of Pharmacy, Northwestern Medicine, Chicago, Illinois, USA., Chandler EL; Department of Pharmacy, Lee Health, Fort Myers, Florida, USA., Zafonte VB; Department of Pharmacy, Jamaica Hospital Medical Center, Richmond Hill, New York, USA., Morrisette T; Department of Clinical Pharmacy and Outcomes Sciences, Medical University of South Carolina College of Pharmacy, Charleston, South Carolina, USA.; Department of Pharmacy Services, Medical University of South Carolina Shawn Jenkins Children's Hospital, Charleston, South Carolina, USA., Gauthier TP; Clinical Pharmacy Enterprise, Baptist Health South Florida, Miami, Florida, USA., Kisgen J; Department of Pharmacy, Sarasota Memorial Health Care System, Sarasota, Florida, USA., Barner A; Department of Pharmacy, Cambridge Health Alliance, Cambridge, Massachusetts, USA., Johnson MD; Division of Infectious Diseases & International Health, Duke University Medical Center, Durham, North Carolina, USA., Tagare RD; Department of Pharmacy, University of Utah Health, Salt Lake City, Utah, USA., Justo JA; Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, South Carolina, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 May 15; Vol. 74 (Suppl_3), pp. e23-e33.
Autor:
Kisgen JJ; Jamie J. Kisgen, Pharm.D., BCPS, is Clinical Assistant Professor, University of Florida College of Pharmacy, Seminole. Hanine Mansour, Pharm.D., BCPS, is Clinical Assistant Professor, Lebanese American University School of Pharmacy, Byblos, Lebanon. Nathan R. Unger, Pharm.D., is Assistant Professor, Nova Southeastern University College of Pharmacy, Palm Beach Gardens, FL. Lindsey M. Childs, Pharm.D., M.P.H., BCPs, is Hepatology Pharmacist, Pharmacy Service, Department of Veterans Affairs, Bay Pines VA Healthcare System, St. Petersburg, FL., Mansour H, Unger NR, Childs LM
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2014 Apr 15; Vol. 71 (8), pp. 621-33.
Publikováno v:
P & T : a peer-reviewed journal for formulary management [P T] 2008 Nov; Vol. 33 (11), pp. 631-41.